Revvity, Inc. (RVTY) stock
Close on Nov 13, 2026Market cap $17.23BP/E 68.3Yield 0.18%
Revvity, Inc. grew revenue 4.6% to $2.94B over the twelve months to Oct 4, 2026. Operating income rose 2.3% to $372.09M, moving the operating margin from 12.9% to 12.6%. Free cash flow was $590.47M, up 18.7% from a year earlier. At the latest close the market valued the company at $17.23B, 68.3 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Oct 4, 2026
Valuation
- Market cap
- $17.23B
- P/E ratio
- 68.3
- Price to sales
- 5.86
- Price to book
- 2.37
- Dividend yield
- 0.18%
- Free cash flow yield
- 3.43%
Fundamentals
- Revenue
- $2.94B
- Net income
- $253.20M
- EPS, diluted
- $2.26
- Free cash flow
- $590.47M
- Book value per share
- $65.02
- Diluted shares
- 112M
Trading
- Next earnings
- Feb 1, 2027 (estimated, before the open)
- Previous close
- $157.02
- Open
- $160.17
- Day's range
- $151.06 – $160.59
- Volume
- 1,306,750
- Average volume (20 days)
- 1,845,192
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 1.03
- 52-week range
- $81.22 – $171.74
- RSI (14 days)
- 48.9
- Volatility (1 year)
- 40.1%
- Relative volume
- 0.73×
- WACC
- 9.5%
On 1 of our idea list: Buyback cannibals
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | RVTY | S&P 500 | Difference | RVTY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.4% | -3.0% | +2.6 pts | ||
| 3 months | +31.4% | -2.8% | +34.2 pts | ||
| Year to date | +59.9% | +11.5% | +48.4 pts | ||
| 1 year | +65.6% | +13.5% | +52.2 pts | ||
| 3 years | +85.1% | +77.7% | +7.4 pts | +22.8% | +21.1% |
| 5 years | -14.9% | +72.6% | −87.5 pts | -3.2% | +11.5% |
| 10 years | +211.8% | +308.2% | −96.4 pts | +12.0% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Revvity filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- Results
- Results
About Revvity
Laboratory Analytical Instruments
Revvity provides health science technologies, expertise, and integrated workflow solutions bridging research, clinical discovery, and medical care. The company operates across two core segments: Life Sciences and Diagnostics. Its Life Sciences division delivers reagents, automated liquid handlers, imaging instruments, detection platforms, and research informatics designed to optimize drug development, genomics, and cellular analysis. Its Diagnostics segment supplies analytical instruments, diagnostic assays, screening kits, and laboratory data management software specializing in prenatal and newborn screening, immunodiagnostics, and infectious disease detection. Revvity serves pharmaceutical and biotechnology corporations, contract research organizations, academic and governmental research institutions, hospitals, clinical laboratories, and healthcare professionals.
Company profile, executives and historyRevvity stock: common questions
What is Revvity's stock price?
RVTY closed at $154.39 on Nov 13, 2026, down 1.67% on the day. Over the past 52 weeks it traded between $81.22 and $171.74.
What is Revvity's market cap?
Revvity was worth $17.23B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is RVTY's P/E ratio?
RVTY trades at 68.3 times earnings, based on diluted earnings per share of $2.26 over the twelve months to Oct 4, 2026.
How much revenue does Revvity make?
Revvity reported revenue of $2.94B for the twelve months to Oct 4, 2026, up 4.6% from a year earlier.
Does Revvity pay a dividend?
Yes. Revvity paid $0.28 per share over the last twelve months, a yield of 0.18% at the latest price.
When does Revvity report earnings next?
Revvity is expected to report Q4 FY2026 results on Feb 1, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has RVTY stock performed over the past year?
Including dividends, RVTY returned +65.6% over the past year, against +13.5% for the S&P 500.
How many RVTY shares are sold short?
7M shares were sold short at the latest FINRA report, 5.88% of the float, or 3.9 days of average trading volume.
Who are Revvity's competitors?
Companies most similar to Revvity by business, industry and size include BIO, BRKR, ILMN, MTD, A.
See a number that looks wrong?